The Food and Drug Administration approved Vertex Pharmaceuticals’ “Journavx” on Thursday, greenlighting the non-opioid painkiller for treating moderate to severe pain in what the FDA considered the ...
The Preeclampsia Foundation announced today the recipients of its 2025 Peter Joseph Pappas Research Grants. Based on the recommendations of its Scientific Advisory Council, the Preeclampsia Foundation ...
SaponiQx, a leader in next-generation saponin-based adjuvant discovery and a subsidiary of Agenus Inc., today announced the publication of their latest preclinical data in the journal Vaccines. The ...
Mothers with multiple sclerosis (MS) have an elevated incidence and prevalence of peripartum mental illness, according to a study published online Jan. 22 in Ne ...
For the past decade or so, I’ve genuinely enjoyed going to the gym. I know, I know… I’m rolling my eyes at myself right along with you. Figuring out how to make working out fun isn’t always easy, but ...